Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S
Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.
Br J Cancer. 2007 Aug 6;97(3):446-51. doi: 10.1038/sj.bjc.6603892. Epub 2007 Jul 10.
We investigated the association between plasma 25(OH)D and the subsequent colorectal cancer incidence risk by a nested case-control study in The Japan Public Health Center-based Prospective Study, covering 375 newly diagnosed cases of colorectal cancer from 38 373 study subjects during a 11.5-year follow-up after blood collection. Two controls were matched per case on sex, age, study area, date of blood draw, and fasting time. In a conditional logistic regression model with matched pairs adjusted for smoking, alcohol consumption, body mass index, physical exercise, vitamin supplement use, and family history of colorectal cancer, plasma 25(OH)D was not significantly associated with colorectal cancer in men or in women. However, the lowest category of plasma 25(OH)D was associated with an elevated risk of rectal cancer in both men (odds ratio (OR), 4.6; 95% confidence interval (CI), 1.0-20) and women (OR, 2.7, 95% CI, 0.94-7.6), compared with the combined category of the other quartiles. Our results suggest that a low level of plasma 25(OH)D may increase the risk of rectal cancer.
我们在日本公共卫生中心前瞻性研究中通过巢式病例对照研究,调查了血浆25(OH)D与后续结直肠癌发病风险之间的关联,该研究涵盖了在采血后11.5年随访期间38373名研究对象中的375例新诊断的结直肠癌病例。每例病例按性别、年龄、研究区域、采血日期和禁食时间匹配两名对照。在一个对吸烟、饮酒、体重指数、体育锻炼、维生素补充剂使用和结直肠癌家族史进行配对调整的条件逻辑回归模型中,血浆25(OH)D在男性或女性中与结直肠癌均无显著关联。然而,与其他四分位数的合并类别相比,血浆25(OH)D最低类别与男性(比值比(OR),4.6;95%置信区间(CI),1.0 - 20)和女性(OR,2.7,95% CI,0.94 - 7.6)的直肠癌风险升高相关。我们的结果表明,血浆25(OH)D水平低可能会增加直肠癌风险。